NEW DELHI: The Delhi high court on Thursday expressed apprehensions over non-utilization of Covid-19 vaccines to its full capacity and noted that there has to be a “sense of urgency”.
The court has directed the country’s leading Covid-19 vaccine manufacturers – Bharat Biotech and Serum Institute of India (SII) to disclose their capacity to manufacture Covaxin and Covishield vaccines.
“We are not utilizing it fully. We are either donating it to foreign countries or selling it to them and are not vaccinating our own people. So there has to be that sense of responsibility and urgency,” a bench of Justices Vipin Sanghi and Rekha Palli said.
The high court directed the two institutes to file separate affidavits on their capacity to manufacture the vaccines on per day/ week/ month basis and also the current optic of the vaccines and how much unused capacity is lying.
“The Union of India (UoI) shall explain the rationale behind keeping strict control over class of persons who can be vaccinated as noticed in our last order. Under the present system, persons above 60 years of age and between 45 to 60 years with co-morbidities can receive vaccination,” high court said.
Delhi High Court Bar Association and Bar Council of Delhi have been asked to file an affidavit disclosing the judicial strength. “It should indicate how many of them would get covered by the existing policy and how many would be left out,” court said.
The court has asked the Delhi government to carry out inspection of medical facilities available in court complexes here and to report if Covid-19 vaccination centres could be set up there and also the short comings in facilities.
The high court asked all the authorities to file their affidavits by March 9 and listed the matter for further hearing on March 10.